The Neurodevelopmental and Behavioral Phenotyping Screening Protocol | MicrobiomeTrials← Back to trialsNCT00271622
The Neurodevelopmental and Behavioral Phenotyping Screening Protocol
RecruitingOBSERVATIONAL
Trial Details
Enrollment target: 5,000 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Amyotrophic Lateral Sclerosis
The goal of this clinical trial is to learn if the drug pridopidine works to treat amyotrophic lateral sclerosis in adul…
Florida City, United StatesEst. completion Mar 2028
Chronic Venous Insufficiency, CVI
This is a prospective, single-arm, pre-post interventional study designed to evaluate the feasibility, safety, and impac…
Bydgoszcz, PolandCompleted May 10, 2028
Phase 2
Recruiting
Down Syndrome-Associated Alzheimer's Disease (DS-AD)
The purpose of the study is to evaluate the effect of mivelsiran in adult participants with early-stage DS-AD and to cha…
Maitland, United StatesEst. completion May 18, 2030